Jubilant Life Sciences is currently trading at Rs. 146.40, up by 4.80 points or 3.39% from its previous closing of Rs. 141.60 on the BSE.
The scrip opened at Rs. 142.00 and has touched a high and low of Rs. 147.00 and Rs. 139.25 respectively. So far 91438 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 190.00 on 14-Mar-2013 and a 52 week low of Rs. 65.10 on 28-Aug-2013.
Last one week high and low of the scrip stood at Rs. 147.00 and Rs. 134.60 respectively. The current market cap of the company is Rs. 2229.94 crore.
The promoters holding in the company stood at 53.95% while Institutions and Non-Institutions held 26.50% and 19.55% respectively.
Jubilant Life Sciences, a significant player in the Nutrition market and ranked amongst the largest manufacturers of Vitamin B3 (Niacin & Niacinamide) in the world has increased prices by 18% for Niacin feed-grade, with immediate effect, for non-contract customers and wherever existing contracts permit.
Jubilant delivers unmatched advantages of consistent quality and availability of Vitamin B3 (Niacin & Niacinamide) to its customers globally. The Company’s nutrition business is backward integrated up to the initial raw material stage with global scale of operations.
Jubilant Life Sciences is a global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1814.50 |
Dr. Reddys Lab | 1341.60 |
Cipla | 1476.45 |
Lupin | 2168.25 |
Zydus Lifesciences | 972.30 |
View more.. |